PAZOPANIB HYDROCHLORIDE

PAZOPANIB HYDROCHLORIDE was reported 26971 times

PAZOPANIB HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DESMOPLASTIC SMALL ROUND CELL TUMOUR 48 0.5517
1 SYNOVIAL SARCOMA METASTATIC 11 0.4583
2 MALIGNANT CONNECTIVE TISSUE NEOPLASM 10 0.4545
3 SOFT TISSUE SARCOMA 109 0.3123
4 UTERINE LEIOMYOSARCOMA 17 0.2125
5 LEIOMYOSARCOMA METASTATIC 14 0.2059
6 RETRO-ORBITAL NEOPLASM 9 0.1698
7 OSTEOSARCOMA METASTATIC 16 0.1684
8 RENAL CELL CARCINOMA STAGE IV 19 0.1681
9 SARCOMA METASTATIC 23 0.1655
10 NEUROFIBROSARCOMA 17 0.1650
11 SPLENIC NECROSIS 13 0.1512
12 SYNOVIAL SARCOMA 14 0.1474
13 ANGIOSARCOMA METASTATIC 17 0.1393
14 POLYCYSTIC LIVER DISEASE 13 0.1226
15 RENAL CANCER METASTATIC 90 0.1169
16 METASTATIC RENAL CELL CARCINOMA 175 0.0955
17 RENAL CANCER RECURRENT 14 0.0952
18 ANGIOSARCOMA 41 0.0889
19 RENAL CELL CARCINOMA RECURRENT 11 0.0866
20 EYELASH DISCOLOURATION 18 0.0822
21 OSTEOMA 13 0.0722
22 SARCOMA UTERUS 9 0.0698
23 METASTASES TO SOFT TISSUE 18 0.0695
24 HAIR COLOUR CHANGES 834 0.0670
25 HAEMOGLOBIN URINE PRESENT 13 0.0640
26 SPLENIC CYST 13 0.0622
27 RHABDOMYOSARCOMA 11 0.0585
28 LEIOMYOSARCOMA 22 0.0571
29 ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL 14 0.0567
30 RENAL CELL CARCINOMA 277 0.0566
31 METASTASES TO PANCREAS 23 0.0519
32 OSTEOSARCOMA 17 0.0442
33 LIPOSARCOMA 14 0.0439
34 METASTASES TO KIDNEY 24 0.0436
35 CLEAR CELL RENAL CELL CARCINOMA 30 0.0431
36 SARCOMA 48 0.0424
37 METASTASES TO THORAX 10 0.0395
38 TUMOUR PAIN 50 0.0379
39 LORDOSIS 13 0.0370
40 SPLENIC LESION 13 0.0351
41 METASTASES TO ADRENALS 32 0.0347
42 SKIN DEPIGMENTATION 45 0.0330
43 PULMONARY NECROSIS 11 0.0323
44 METASTASES TO LUNG 370 0.0320
45 METASTASES TO CHEST WALL 11 0.0317
46 PNEUMOTHORAX SPONTANEOUS 20 0.0295
47 METASTASES TO THE MEDIASTINUM 12 0.0291
48 METASTASES TO PELVIS 17 0.0269
49 HEPATOBILIARY DISEASE 16 0.0256
50 INVESTIGATION 79 0.0252
51 RENAL SURGERY 15 0.0230
52 TUMOUR EXCISION 18 0.0224
53 MUSCLE MASS 10 0.0221
54 PROTEIN URINE 20 0.0221
55 TUMOUR NECROSIS 23 0.0218
56 PROTHROMBIN TIME ABNORMAL 15 0.0217
57 METASTASES TO STOMACH 8 0.0204
58 URINARY SEDIMENT PRESENT 13 0.0202
59 TUMOUR RUPTURE 11 0.0196
60 SKIN HYPOPIGMENTATION 34 0.0192
61 METASTASES TO PERITONEUM 48 0.0190
62 TUMOUR INVASION 9 0.0185
63 METASTASES TO PLEURA 19 0.0181
64 HOSPICE CARE 178 0.0180
65 METASTASES TO SPINE 60 0.0178
66 EMERGENCY CARE EXAMINATION 12 0.0177
67 INTRACRANIAL MASS 16 0.0169
68 RECALL PHENOMENON 14 0.0167
69 MALIGNANT NEOPLASM PROGRESSION 1675 0.0163
70 METASTASES TO ABDOMINAL CAVITY 8 0.0163
71 PARANEOPLASTIC SYNDROME 10 0.0148
72 EYE COLOUR CHANGE 15 0.0147
73 METASTASIS 105 0.0147
74 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 321 0.0138
75 MALIGNANT PLEURAL EFFUSION 23 0.0136
76 RED BLOOD CELL ABNORMALITY 13 0.0135
77 RED BLOOD CELLS URINE POSITIVE 13 0.0134
78 BLOOD BILIRUBIN ABNORMAL 17 0.0133
79 METASTASES TO CENTRAL NERVOUS SYSTEM 171 0.0132
80 METASTASES TO LYMPH NODES 89 0.0132
81 BONE NEOPLASM 14 0.0130
82 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 13 0.0125
83 SCLERAL DISCOLOURATION 8 0.0122
84 CANCER PAIN 31 0.0121
85 OSTEOCHONDROSIS 14 0.0121
86 PNEUMOTHORAX 191 0.0120
87 TUMOUR HAEMORRHAGE 34 0.0119
88 NEPHROTIC SYNDROME 81 0.0118
89 CELL DEATH 23 0.0116
90 SPINAL CORD NEOPLASM 10 0.0115
91 AMYLASE INCREASED 42 0.0114
92 ENTEROCUTANEOUS FISTULA 10 0.0113
93 RENAL NEOPLASM 24 0.0113
94 FAECES PALE 25 0.0112
95 LYMPHADENOPATHY MEDIASTINAL 21 0.0110
96 NEOPLASM 126 0.0110
97 HEPATIC MASS 21 0.0109
98 PROTEINURIA 203 0.0107
99 HAEMATOCRIT ABNORMAL 13 0.0106
100 LYMPHANGIOSIS CARCINOMATOSA 11 0.0106
101 OSTEOLYSIS 21 0.0103
102 METASTASES TO BONE 168 0.0102
103 VENA CAVA THROMBOSIS 17 0.0102
104 GASTROINTESTINAL STROMAL TUMOUR 27 0.0102
105 METASTASES TO LIVER 177 0.0101
106 RADIOTHERAPY 19 0.0099
107 SECOND PRIMARY MALIGNANCY 82 0.0098
108 NEOPLASM RECURRENCE 33 0.0097
109 METASTASES TO SKIN 10 0.0097
110 DYSENTERY 18 0.0097
111 BLOOD BILIRUBIN INCREASED 261 0.0097
112 NEPHRECTOMY 14 0.0094
113 PANCREATIC MASS 10 0.0093
114 HEPATOTOXICITY 208 0.0093
115 POLYCYTHAEMIA 19 0.0092
116 THYROID FUNCTION TEST ABNORMAL 38 0.0091
117 AGEUSIA 227 0.0091
118 RECURRENT CANCER 37 0.0091
119 HYPERLEUKOCYTOSIS 8 0.0090
120 ABDOMINAL NEOPLASM 8 0.0090
121 RENAL MASS 18 0.0087
122 DISEASE PROGRESSION 1019 0.0086
123 YELLOW SKIN 40 0.0085
124 MEAN CELL HAEMOGLOBIN INCREASED 14 0.0084
125 ELECTROCARDIOGRAM CHANGE 8 0.0084
126 BLOOD THYROID STIMULATING HORMONE INCREASED 77 0.0084
127 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 79 0.0083
128 PROTEIN URINE PRESENT 41 0.0082
129 HYPOGEUSIA 16 0.0082
130 HYPOTHYROIDISM 258 0.0081
131 SKIN OEDEMA 8 0.0080
132 WHITE BLOOD CELLS URINE POSITIVE 15 0.0080
133 JAUNDICE CHOLESTATIC 28 0.0079
134 METASTATIC NEOPLASM 34 0.0079
135 HEPATIC FUNCTION ABNORMAL 293 0.0078
136 MEAN CELL VOLUME INCREASED 20 0.0078
137 HEPATIC LESION 33 0.0076
138 THYROID CANCER 88 0.0073
139 JAUNDICE 196 0.0073
140 LUNG OPACITY 19 0.0072
141 BONE LESION 26 0.0072
142 GASTRIC ULCER PERFORATION 9 0.0071
143 GLOSSITIS 25 0.0070
144 FEMALE GENITAL TRACT FISTULA 12 0.0070
145 LUNG NEOPLASM 30 0.0070
146 NEOPLASM PROGRESSION 242 0.0070
147 EXPOSED BONE IN JAW 15 0.0069
148 NONINFECTIVE GINGIVITIS 10 0.0069
149 PULMONARY MASS 102 0.0068
150 CONCOMITANT DISEASE AGGRAVATED 42 0.0068
151 DYSGEUSIA 504 0.0068
152 HYPERTENSIVE CRISIS 75 0.0067
153 LEFT VENTRICULAR DYSFUNCTION 45 0.0067
154 HYPERKERATOSIS 37 0.0067
155 CONTRAINDICATION TO MEDICAL TREATMENT 10 0.0065
156 BRAIN NEOPLASM 60 0.0065
157 ORAL MUCOSAL ERYTHEMA 10 0.0065
158 ORAL PAIN 140 0.0062
159 ADENOCARCINOMA 14 0.0062
160 EJECTION FRACTION DECREASED 97 0.0062
161 INTESTINAL PERFORATION 70 0.0062
162 VENTRICULAR HYPOKINESIA 20 0.0062
163 PERFORMANCE STATUS DECREASED 29 0.0062
164 DECREASED APPETITE 1437 0.0062
165 HEPATIC NEOPLASM 20 0.0061
166 LIVER FUNCTION TEST ABNORMAL 175 0.0060
167 GASTROINTESTINAL PERFORATION 25 0.0060
168 LIPASE INCREASED 46 0.0060
169 HYPERTENSION 1270 0.0060
170 ORAL MUCOSAL EXFOLIATION 9 0.0059
171 ALANINE AMINOTRANSFERASE INCREASED 365 0.0059
172 PALLIATIVE CARE 9 0.0059
173 AORTIC ARTERIOSCLEROSIS 15 0.0058
174 HEPATIC ENZYME INCREASED 389 0.0057
175 URINARY BLADDER HAEMORRHAGE 12 0.0057
176 HYPERBILIRUBINAEMIA 59 0.0057
177 PERIPHERAL ARTERY OCCLUSION 8 0.0057
178 CONCOMITANT DISEASE PROGRESSION 11 0.0056
179 DIARRHOEA 3615 0.0056
180 LIVER FUNCTION TEST INCREASED 118 0.0055
181 ASPARTATE AMINOTRANSFERASE INCREASED 289 0.0054
182 STOMATITIS 328 0.0054
183 NECROSIS 30 0.0054
184 CARDIAC DYSFUNCTION 20 0.0054
185 ANAL HAEMORRHAGE 15 0.0054
186 ASCITES 157 0.0053
187 ORTHOPNOEA 17 0.0053
188 DEATH 4592 0.0053
189 THYROIDITIS 16 0.0053
190 DISSEMINATED INTRAVASCULAR COAGULATION 75 0.0053
191 RETINAL TEAR 13 0.0053
192 BILE DUCT OBSTRUCTION 10 0.0053
193 TRANSAMINASES INCREASED 117 0.0053
194 HYPERTHYROIDISM 76 0.0052
195 BLOOD PRESSURE INCREASED 787 0.0051
196 ADRENOCORTICAL INSUFFICIENCY ACUTE 10 0.0051
197 EXOPHTHALMOS 11 0.0051
198 HAEMORRHAGE URINARY TRACT 13 0.0051
199 RENAL CANCER STAGE IV 14 0.0051
200 GASTROINTESTINAL OEDEMA 9 0.0051
201 BONE CANCER 22 0.0051
202 HEPATITIS FULMINANT 15 0.0051
203 INHIBITORY DRUG INTERACTION 8 0.0051
204 HEPATIC ENZYME ABNORMAL 25 0.0050
205 MUCOSAL INFLAMMATION 131 0.0050
206 GASTROINTESTINAL TOXICITY 24 0.0050
207 LIVER DISORDER 214 0.0048
208 SMALL INTESTINAL PERFORATION 9 0.0048
209 HYPOALBUMINAEMIA 37 0.0048
210 HYPOPROTEINAEMIA 9 0.0047
211 EATING DISORDER 101 0.0047
212 THYROID DISORDER 73 0.0047
213 TONGUE ULCERATION 16 0.0047
214 HEPATIC CYST 16 0.0047
215 PIGMENTATION DISORDER 29 0.0047
216 GAMMA-GLUTAMYLTRANSFERASE INCREASED 104 0.0047
217 PLEURAL EFFUSION 283 0.0046
218 HYPERURICAEMIA 19 0.0046
219 SPINAL CORD COMPRESSION 18 0.0046
220 BLOOD ALKALINE PHOSPHATASE INCREASED 113 0.0045
221 DUODENAL ULCER 32 0.0045
222 APPETITE DISORDER 30 0.0045
223 RENAL CANCER 215 0.0045
224 INTRA-ABDOMINAL FLUID COLLECTION 8 0.0045
225 TUMOUR LYSIS SYNDROME 39 0.0044
226 GASTRIC PERFORATION 12 0.0044
227 HAEMOGLOBIN INCREASED 20 0.0044
228 CARDIOTOXICITY 39 0.0044
229 INTERNATIONAL NORMALISED RATIO ABNORMAL 15 0.0044
230 HAEMOPTYSIS 121 0.0043
231 TASTE DISORDER 88 0.0043
232 PNEUMOPERITONEUM 8 0.0043
233 BILIRUBIN CONJUGATED INCREASED 10 0.0043
234 HEPATOCELLULAR INJURY 60 0.0042
235 CARDIAC FAILURE ACUTE 28 0.0042
236 INTRA-ABDOMINAL HAEMORRHAGE 10 0.0042
237 SKIN DISCOLOURATION 188 0.0041
238 PARESIS 9 0.0040
239 COMPUTERISED TOMOGRAM ABNORMAL 9 0.0040
240 OSTEONECROSIS OF JAW 98 0.0040
241 RENAL HAEMORRHAGE 8 0.0039
242 NEOPLASM MALIGNANT 262 0.0039
243 IMMUNE-MEDIATED HEPATITIS 8 0.0039
244 HAEMOLYTIC URAEMIC SYNDROME 9 0.0039
245 WOUND DEHISCENCE 13 0.0038
246 HEPATITIS TOXIC 10 0.0038
247 GINGIVAL PAIN 30 0.0038
248 PROTEIN TOTAL INCREASED 10 0.0038
249 CHOLESTASIS 72 0.0037
250 LARGE INTESTINE PERFORATION 26 0.0037
251 TERMINAL STATE 25 0.0037
252 CHROMATURIA 84 0.0037
253 SKIN TOXICITY 21 0.0037
254 CACHEXIA 19 0.0037
255 TROPONIN INCREASED 28 0.0037
256 GOITRE 15 0.0037
257 FLANK PAIN 34 0.0036
258 ELECTROCARDIOGRAM T WAVE INVERSION 8 0.0036
259 DUODENITIS 11 0.0036
260 EPIGASTRIC DISCOMFORT 14 0.0036
261 HEPATIC FAILURE 107 0.0035
262 BRAIN OPERATION 8 0.0035
263 SKIN ATROPHY 20 0.0035
264 MONOPLEGIA 15 0.0034
265 HAEMOTHORAX 10 0.0034
266 FAECES SOFT 25 0.0034
267 HYPERAESTHESIA 28 0.0034
268 ABDOMINAL MASS 9 0.0034
269 SKIN ULCER 86 0.0033
270 IMPAIRED HEALING 109 0.0033
271 ABDOMINAL RIGIDITY 9 0.0033
272 BENIGN PROSTATIC HYPERPLASIA 17 0.0033
273 FOOD INTOLERANCE 12 0.0033
274 ACUTE CORONARY SYNDROME 27 0.0033
275 PANCREATIC DISORDER 16 0.0032
276 RETCHING 69 0.0032
277 RENAL FUNCTION TEST ABNORMAL 15 0.0032
278 BLOOD LACTATE DEHYDROGENASE INCREASED 51 0.0032
279 PLATELET COUNT DECREASED 342 0.0032
280 FATIGUE 2495 0.0032
281 REGURGITATION 11 0.0032
282 PROTEIN TOTAL DECREASED 12 0.0032
283 BLOOD CREATININE ABNORMAL 11 0.0032
284 CARDIOMYOPATHY 47 0.0032
285 WEIGHT DECREASED 881 0.0032
286 FEEDING DISORDER 64 0.0032
287 PLATELET COUNT ABNORMAL 19 0.0031
288 AORTIC DISSECTION 13 0.0031
289 GLOSSODYNIA 70 0.0031
290 BLOOD CHLORIDE DECREASED 8 0.0031
291 HAEMORRHAGE SUBCUTANEOUS 11 0.0031
292 PULMONARY PAIN 9 0.0031
293 PRODUCT USE IN UNAPPROVED INDICATION 764 0.0031
294 NAUSEA 2422 0.0031
295 BLOOD URINE PRESENT 58 0.0031
296 NAIL DISCOLOURATION 12 0.0030
297 THERAPY CHANGE 30 0.0030
298 HICCUPS 25 0.0030
299 DEHYDRATION 401 0.0030
300 BLOOD CREATININE INCREASED 196 0.0030
301 OCULAR ICTERUS 13 0.0030
302 HYPERCALCAEMIA 37 0.0030
303 VOMITING 1407 0.0030
304 CARDIAC TAMPONADE 14 0.0029
305 THERAPY CESSATION 151 0.0029
306 DRUG-INDUCED LIVER INJURY 92 0.0029
307 AUTOIMMUNE HAEMOLYTIC ANAEMIA 10 0.0029
308 EPISTAXIS 218 0.0029
309 RED CELL DISTRIBUTION WIDTH INCREASED 12 0.0029
310 HYPERTRANSAMINASAEMIA 20 0.0029
311 BLOOD DISORDER 23 0.0029
312 LUNG CONSOLIDATION 8 0.0029
313 PSYCHOMOTOR RETARDATION 8 0.0028
314 BLOOD PRESSURE DIASTOLIC INCREASED 13 0.0028
315 BLISTER 158 0.0028
316 PULMONARY HAEMORRHAGE 22 0.0028
317 HYDRONEPHROSIS 21 0.0028
318 PARAPLEGIA 8 0.0028
319 BRAIN OEDEMA 35 0.0028
320 LIVER INJURY 68 0.0028
321 PERICARDIAL EFFUSION 64 0.0028
322 THERAPY PARTIAL RESPONDER 43 0.0028
323 GENERAL PHYSICAL HEALTH DETERIORATION 317 0.0027
324 NONSPECIFIC REACTION 15 0.0027
325 RENAL IMPAIRMENT 229 0.0027
326 RETINAL DETACHMENT 25 0.0027
327 BLOOD PRESSURE ABNORMAL 54 0.0027
328 SHOCK HAEMORRHAGIC 22 0.0027
329 HISTIOCYTOSIS HAEMATOPHAGIC 8 0.0027
330 HEPATITIS 68 0.0027
331 MULTIPLE ORGAN DYSFUNCTION SYNDROME 75 0.0026
332 PROCTALGIA 17 0.0026
333 ANAL FISTULA 14 0.0026
334 DYSCHEZIA 8 0.0026
335 THROMBOCYTOPENIA 293 0.0026
336 BRAIN NATRIURETIC PEPTIDE INCREASED 8 0.0026
337 ORAL DISCOMFORT 36 0.0026
338 SCOLIOSIS 16 0.0026
339 REHABILITATION THERAPY 10 0.0026
340 DYSPHONIA 150 0.0026
341 HYPERTRIGLYCERIDAEMIA 15 0.0026
342 PATHOLOGICAL FRACTURE 13 0.0026
343 NODULE 33 0.0025
344 BLOOD ALBUMIN DECREASED 20 0.0025
345 CHOLECYSTITIS 30 0.0025
346 HAEMATURIA 86 0.0025
347 GENERALISED OEDEMA 31 0.0025
348 AZOTAEMIA 10 0.0025
349 ABDOMINAL DISCOMFORT 418 0.0025
350 HEPATITIS CHOLESTATIC 15 0.0025
351 ASTHENIA 932 0.0025
352 BLOOD POTASSIUM INCREASED 40 0.0025
353 BRAIN NEOPLASM MALIGNANT 11 0.0025
354 BONE MARROW FAILURE 50 0.0025
355 THROMBOCYTOSIS 9 0.0025
356 MASS 34 0.0024
357 ENTEROCOLITIS 14 0.0024
358 BLOOD URIC ACID INCREASED 14 0.0024
359 HYPERKALAEMIA 85 0.0024
360 HAEMATOTOXICITY 23 0.0024
361 HAEMATEMESIS 61 0.0024
362 SPINAL OSTEOARTHRITIS 21 0.0024
363 SPINAL PAIN 28 0.0024
364 ABDOMINAL PAIN UPPER 490 0.0024
365 HYPERCHLORHYDRIA 14 0.0024
366 ADVERSE DRUG REACTION 211 0.0023
367 FLATULENCE 133 0.0023
368 VITREOUS FLOATERS 23 0.0023
369 ILEUS 29 0.0023
370 CEREBRAL ISCHAEMIA 12 0.0023
371 HAEMOGLOBIN ABNORMAL 15 0.0023
372 DECUBITUS ULCER 19 0.0023
373 FUNCTIONAL GASTROINTESTINAL DISORDER 8 0.0023
374 FAECES DISCOLOURED 50 0.0023
375 CARDIAC FAILURE 184 0.0023
376 APHAGIA 11 0.0023
377 BLOOD SODIUM DECREASED 43 0.0023
378 DRUG INTOLERANCE 219 0.0023
379 GINGIVAL SWELLING 10 0.0023
380 RENAL PAIN 24 0.0023
381 GASTRIC ULCER 43 0.0023
382 MUSCULOSKELETAL CHEST PAIN 35 0.0023
383 HAEMORRHOIDAL HAEMORRHAGE 11 0.0023
384 DECREASED IMMUNE RESPONSIVENESS 22 0.0022
385 ABDOMINAL PAIN 520 0.0022
386 MOUTH ULCERATION 47 0.0022
387 ANAL ABSCESS 12 0.0022
388 GINGIVITIS 12 0.0022
389 APPARENT DEATH 8 0.0022
390 CHEILITIS 12 0.0022
391 HIP SURGERY 12 0.0022
392 BLOOD TEST ABNORMAL 31 0.0022
393 FLUID INTAKE REDUCED 11 0.0022
394 GINGIVAL BLEEDING 30 0.0022
395 ENTERITIS 14 0.0022
396 MOUTH HAEMORRHAGE 16 0.0022
397 LYMPHADENOPATHY 77 0.0022
398 INCREASED TENDENCY TO BRUISE 20 0.0022
399 SENSITIVE SKIN 16 0.0022
400 PNEUMONITIS 59 0.0022
401 CONGESTIVE CARDIOMYOPATHY 9 0.0022
402 HEPATITIS ACUTE 14 0.0022
403 LEUKOENCEPHALOPATHY 8 0.0021
404 C-REACTIVE PROTEIN INCREASED 78 0.0021
405 ILL-DEFINED DISORDER 130 0.0021
406 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 8 0.0021
407 PANCREATITIS ACUTE 47 0.0021
408 ASPHYXIA 17 0.0021
409 ELECTROLYTE IMBALANCE 24 0.0021
410 MALAISE 904 0.0021
411 TONGUE DISCOLOURATION 9 0.0021
412 TRANSIENT ISCHAEMIC ATTACK 69 0.0020
413 ABDOMINAL ABSCESS 9 0.0020
414 PURPURA 18 0.0020
415 BLOOD CREATINE INCREASED 9 0.0020
416 GASTROINTESTINAL SOUNDS ABNORMAL 10 0.0020
417 GASTRITIS 53 0.0020
418 DYSPEPSIA 198 0.0020
419 PALLOR 54 0.0020
420 DERMATITIS ACNEIFORM 12 0.0020
421 ANAEMIA 376 0.0020
422 MALNUTRITION 22 0.0020
423 BLOOD PRESSURE SYSTOLIC INCREASED 38 0.0019
424 HAEMORRHAGE INTRACRANIAL 29 0.0019
425 GROIN PAIN 17 0.0019
426 EMBOLISM 16 0.0019
427 HEMIPLEGIA 16 0.0019
428 GENERAL PHYSICAL CONDITION ABNORMAL 13 0.0019
429 CEREBRAL HAEMORRHAGE 68 0.0019
430 FURUNCLE 15 0.0019
431 STRESS CARDIOMYOPATHY 11 0.0019
432 RENAL CYST 15 0.0019
433 APHASIA 57 0.0019
434 NO THERAPEUTIC RESPONSE 23 0.0019
435 HYPONATRAEMIA 106 0.0019
436 HEPATIC PAIN 8 0.0019
437 PANCREATITIS 99 0.0019
438 PURULENT DISCHARGE 8 0.0019
439 ANAL FISSURE 10 0.0019
440 APHONIA 26 0.0019
441 INCOHERENT 12 0.0019
442 PULMONARY OEDEMA 82 0.0018
443 ABNORMAL FAECES 15 0.0018
444 TOOTHACHE 33 0.0018
445 ERYTHEMA MULTIFORME 17 0.0018
446 LUNG DISORDER 89 0.0018
447 MUSCULOSKELETAL PAIN 95 0.0018
448 APHTHOUS ULCER 14 0.0018
449 BLOOD UREA INCREASED 30 0.0018
450 RED BLOOD CELL COUNT DECREASED 51 0.0018
451 CONSTIPATION 388 0.0018
452 MENTAL STATUS CHANGES 49 0.0018
453 BLOOD PRESSURE SYSTOLIC DECREASED 8 0.0018
454 RESPIRATORY FAILURE 128 0.0018
455 DISEASE COMPLICATION 8 0.0017
456 ONYCHOCLASIS 12 0.0017
457 SUNBURN 13 0.0017
458 PULMONARY THROMBOSIS 19 0.0017
459 OESOPHAGITIS 19 0.0017
460 SKIN NECROSIS 9 0.0017
461 PAROSMIA 13 0.0017
462 HAEMATOCRIT DECREASED 34 0.0017
463 CATARACT OPERATION 10 0.0017
464 ACUTE HEPATIC FAILURE 23 0.0017
465 SKIN DISORDER 56 0.0017
466 SURGERY 98 0.0017
467 MYOCARDIAL ISCHAEMIA 19 0.0017
468 PELVIC FRACTURE 13 0.0017
469 INTERNAL HAEMORRHAGE 19 0.0017
470 ARTERIOSCLEROSIS CORONARY ARTERY 11 0.0017
471 DYSURIA 61 0.0017
472 ATELECTASIS 16 0.0017
473 HEART RATE DECREASED 58 0.0017
474 SKIN MASS 11 0.0016
475 HEPATIC CYTOLYSIS 21 0.0016
476 THROMBOTIC MICROANGIOPATHY 16 0.0016
477 HYPOCALCAEMIA 31 0.0016
478 CEREBRAL INFARCTION 40 0.0016
479 DRUG ERUPTION 29 0.0016
480 RENAL DISORDER 76 0.0016
481 PULMONARY EMBOLISM 155 0.0016
482 GLOMERULAR FILTRATION RATE DECREASED 20 0.0016
483 ANURIA 14 0.0016
484 CARDIOMEGALY 20 0.0016
485 BLOOD MAGNESIUM DECREASED 14 0.0016
486 HIATUS HERNIA 21 0.0016
487 SENSORY DISTURBANCE 26 0.0016
488 LUNG INFECTION 25 0.0016
489 INFARCTION 11 0.0016
490 URINE OUTPUT DECREASED 14 0.0016
491 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 12 0.0016
492 MELAENA 35 0.0016
493 HAEMORRHOIDS 31 0.0016
494 CHOLECYSTITIS ACUTE 9 0.0016
495 LUNG INFILTRATION 14 0.0016
496 DECREASED ACTIVITY 17 0.0016
497 ADRENAL INSUFFICIENCY 19 0.0016
498 GASTRIC HAEMORRHAGE 18 0.0016
499 MYOSITIS 14 0.0016
500 THROMBOSIS 125 0.0016
501 ALOPECIA 303 0.0015
502 FAILURE TO THRIVE 8 0.0015
503 WOUND 43 0.0015
504 BONE PAIN 90 0.0015
505 HEMIPARESIS 26 0.0015
506 TRANSFUSION 16 0.0015
507 HEPATOMEGALY 15 0.0015
508 HYPOAESTHESIA ORAL 23 0.0015
509 ORAL CANDIDIASIS 20 0.0015
510 BLOOD COUNT ABNORMAL 23 0.0015
511 PHOTOSENSITIVITY REACTION 25 0.0015
512 HYPOACUSIS 65 0.0015
513 ABDOMINAL DISTENSION 157 0.0015
514 DYSPNOEA 848 0.0015
515 DIARRHOEA HAEMORRHAGIC 14 0.0015
516 BLOOD PRESSURE INADEQUATELY CONTROLLED 9 0.0015
517 OEDEMA PERIPHERAL 181 0.0015
518 COLITIS ISCHAEMIC 10 0.0015
519 HYPERGLYCAEMIA 54 0.0015
520 HAEMOGLOBIN DECREASED 152 0.0015
521 LETHARGY 85 0.0015
522 PYREXIA 511 0.0015
523 DRY THROAT 15 0.0015
524 NEUTROPHIL COUNT INCREASED 15 0.0015
525 BACK PAIN 340 0.0015
526 FEBRILE NEUTROPENIA 97 0.0015
527 EAR DISCOMFORT 15 0.0015
528 WOUND INFECTION 16 0.0015
529 DYSPNOEA EXERTIONAL 55 0.0015
530 OEDEMA 79 0.0015
531 CHOLANGITIS 9 0.0015
532 HOSPITALISATION 223 0.0014
533 COLITIS 55 0.0014
534 PERITONITIS 30 0.0014
535 NASAL DRYNESS 9 0.0014
536 HAEMATOCHEZIA 79 0.0014
537 BONE DISORDER 26 0.0014
538 ACUTE PULMONARY OEDEMA 8 0.0014
539 FISTULA 16 0.0014
540 SUDDEN DEATH 15 0.0014
541 SKIN HAEMORRHAGE 21 0.0014
542 HAEMORRHAGIC STROKE 11 0.0014
543 PAIN IN EXTREMITY 415 0.0014
544 HYPOPHAGIA 36 0.0014
545 DYSPHAGIA 132 0.0014
546 HAEMATOMA 36 0.0014
547 PYELONEPHRITIS 12 0.0014
548 LOCAL SWELLING 24 0.0014
549 BLOOD PRESSURE FLUCTUATION 33 0.0014
550 RENAL FAILURE 182 0.0014
551 UTERINE CANCER 11 0.0014
552 LIMB DISCOMFORT 42 0.0014
553 MENINGITIS 9 0.0013
554 SINUS HEADACHE 8 0.0013
555 COUGH 377 0.0013
556 PETECHIAE 14 0.0013
557 GASTROINTESTINAL DISORDER 120 0.0013
558 PROTHROMBIN TIME PROLONGED 8 0.0013
559 SKIN EXFOLIATION 112 0.0013
560 PARALYSIS 19 0.0013
561 LABORATORY TEST ABNORMAL 39 0.0013
562 HAEMORRHAGE 138 0.0013
563 INGUINAL HERNIA 8 0.0013
564 ECCHYMOSIS 9 0.0013
565 GASTRIC DISORDER 45 0.0013
566 CENTRAL NERVOUS SYSTEM LESION 18 0.0013
567 MYOCARDITIS 15 0.0013
568 RESPIRATORY ARREST 36 0.0013
569 BOWEL MOVEMENT IRREGULARITY 10 0.0013
570 RECTAL HAEMORRHAGE 56 0.0013
571 DRUG ADMINISTRATION ERROR 40 0.0013
572 CANDIDA INFECTION 22 0.0013
573 OVARIAN CANCER 12 0.0013
574 DRUG INTERACTION 206 0.0013
575 FREQUENT BOWEL MOVEMENTS 35 0.0013
576 ADVERSE EVENT 119 0.0013
577 OLIGURIA 8 0.0013
578 GASTROINTESTINAL HAEMORRHAGE 107 0.0013
579 RASH GENERALISED 33 0.0013
580 BACTERAEMIA 15 0.0013
581 INTERSTITIAL LUNG DISEASE 61 0.0013
582 FLUID RETENTION 64 0.0013
583 CHEST PAIN 233 0.0013
584 NEUTROPENIA 170 0.0012
585 TENDERNESS 13 0.0012
586 BLOOD CALCIUM DECREASED 14 0.0012
587 TONGUE DISORDER 9 0.0012
588 MITRAL VALVE INCOMPETENCE 14 0.0012
589 CIRCULATORY COLLAPSE 21 0.0012
590 ORAL DISORDER 9 0.0012
591 ABDOMINAL PAIN LOWER 31 0.0012
592 RHABDOMYOLYSIS 51 0.0012
593 MUSCLE SPASMS 224 0.0012
594 HYPOPHOSPHATAEMIA 9 0.0012
595 SHOCK 28 0.0012
596 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
597 HIP FRACTURE 39 0.0012
598 SPEECH DISORDER 63 0.0012
599 PNEUMONIA BACTERIAL 11 0.0012
600 ULCER 19 0.0012
601 PRODUCTIVE COUGH 57 0.0012
602 GASTROOESOPHAGEAL REFLUX DISEASE 96 0.0012
603 QUALITY OF LIFE DECREASED 16 0.0012
604 CARDIOGENIC SHOCK 17 0.0012
605 PROCEDURAL COMPLICATION 9 0.0012
606 ABASIA 29 0.0012
607 POLYNEUROPATHY 14 0.0012
608 PERIPHERAL COLDNESS 16 0.0012
609 ATRIOVENTRICULAR BLOCK 9 0.0012
610 PANCYTOPENIA 65 0.0012
611 NEPHROPATHY TOXIC 13 0.0012
612 MULTI-ORGAN FAILURE 20 0.0012
613 ACUTE KIDNEY INJURY 176 0.0011
614 FEELING COLD 32 0.0011
615 RASH 501 0.0011
616 HEADACHE 718 0.0011
617 CONFUSIONAL STATE 185 0.0011
618 MUSCULAR WEAKNESS 130 0.0011
619 NAIL DISORDER 10 0.0011
620 DEFAECATION URGENCY 8 0.0011
621 BLOOD CALCIUM INCREASED 10 0.0011
622 HYPERCHOLESTEROLAEMIA 11 0.0011
623 ACUTE RESPIRATORY DISTRESS SYNDROME 20 0.0011
624 DYSSTASIA 33 0.0011
625 DRUG INEFFECTIVE 1489 0.0011
626 DRUG RESISTANCE 29 0.0011
627 NEUTROPHIL COUNT DECREASED 46 0.0011
628 CYST 14 0.0011
629 CEREBROVASCULAR ACCIDENT 191 0.0011
630 THERMAL BURN 8 0.0011
631 BODY TEMPERATURE INCREASED 23 0.0011
632 EYE HAEMORRHAGE 15 0.0011
633 THERAPEUTIC RESPONSE DECREASED 68 0.0011
634 MOVEMENT DISORDER 36 0.0011
635 MYALGIA 190 0.0011
636 BODY TEMPERATURE DECREASED 11 0.0011
637 HYPERSOMNIA 32 0.0011
638 PAIN 681 0.0011
639 DRUG DOSE OMISSION 183 0.0011
640 AMNESIA 72 0.0011
641 HEART RATE IRREGULAR 25 0.0011
642 CARDIAC ARREST 91 0.0011
643 SALIVARY HYPERSECRETION 11 0.0011
644 ENCEPHALOPATHY 27 0.0011
645 DERMATITIS 23 0.0011
646 LUNG NEOPLASM MALIGNANT 45 0.0011
647 LOWER LIMB FRACTURE 21 0.0011
648 INTERNATIONAL NORMALISED RATIO INCREASED 31 0.0011
649 UROSEPSIS 10 0.0011
650 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0011
651 CONTUSION 104 0.0011
652 URINARY INCONTINENCE 32 0.0011
653 SUBARACHNOID HAEMORRHAGE 11 0.0011
654 SLUGGISHNESS 11 0.0011
655 GAIT DISTURBANCE 206 0.0011
656 BLOOD TRIGLYCERIDES INCREASED 19 0.0011
657 SKIN FISSURES 21 0.0011
658 HEPATIC STEATOSIS 20 0.0011
659 HEPATIC ENCEPHALOPATHY 10 0.0011
660 NEURALGIA 26 0.0011
661 ISCHAEMIC STROKE 19 0.0011
662 ARTERIOSCLEROSIS 10 0.0011
663 REBOUND EFFECT 12 0.0011
664 CYTOPENIA 13 0.0011
665 SKIN LESION 29 0.0011
666 DRY SKIN 141 0.0011
667 WEIGHT FLUCTUATION 11 0.0011
668 INFECTION 152 0.0010
669 GAIT INABILITY 35 0.0010
670 MALIGNANT MELANOMA 14 0.0010
671 TOOTH EXTRACTION 13 0.0010
672 PNEUMONIA 337 0.0010
673 MUSCLE STRAIN 9 0.0010
674 SINUS BRADYCARDIA 10 0.0010
675 ELECTROCARDIOGRAM QT PROLONGED 37 0.0010
676 CARDIAC DISORDER 96 0.0010
677 THERAPY NON-RESPONDER 46 0.0010
678 DRY MOUTH 83 0.0010
679 HYPOGLYCAEMIA 49 0.0010
680 DISORIENTATION 40 0.0010
681 GALLBLADDER DISORDER 18 0.0010
682 INTESTINAL OBSTRUCTION 38 0.0010
683 INFLAMMATION 52 0.0010
684 ATRIAL FIBRILLATION 98 0.0010
685 PERIPHERAL SWELLING 155 0.0010
686 OROPHARYNGEAL PAIN 93 0.0010
687 HAEMOLYTIC ANAEMIA 9 0.0010
688 GOUT 18 0.0010
689 ATRIAL FLUTTER 8 0.0010
690 RASH MACULAR 35 0.0010
691 ANAL INCONTINENCE 9 0.0010
692 WHITE BLOOD CELL COUNT DECREASED 108 0.0010
693 SEIZURE 115 0.0010
694 SEPSIS 111 0.0010
695 INCREASED APPETITE 19 0.0010
696 SENSORY LOSS 8 0.0010
697 STENT PLACEMENT 8 0.0010
698 LYMPHOPENIA 14 0.0010
699 MUSCULOSKELETAL DISCOMFORT 17 0.0010
700 DIALYSIS 14 0.0010
701 PULMONARY CONGESTION 13 0.0010
702 POST PROCEDURAL INFECTION 8 0.0010
703 DRUG LEVEL DECREASED 10 0.0010
704 SKIN INFECTION 11 0.0010
705 SMALL INTESTINAL OBSTRUCTION 12 0.0010
706 GRAND MAL CONVULSION 9 0.0010
707 DIVERTICULITIS 27 0.0010
708 MYELOSUPPRESSION 35 0.0010
709 HAIR DISORDER 8 0.0010
710 BURNING SENSATION 68 0.0010
711 LYMPHOCYTE COUNT DECREASED 17 0.0010
712 NERVOUS SYSTEM DISORDER 30 0.0010
713 EOSINOPHIL COUNT INCREASED 8 0.0010
714 INCONTINENCE 10 0.0009
715 VASCULITIS 11 0.0009
716 BRADYCARDIA 50 0.0009
717 CYSTITIS 30 0.0009
718 HYPOKALAEMIA 43 0.0009
719 SKIN HYPERPIGMENTATION 8 0.0009
720 HERNIA 18 0.0009
721 DYSARTHRIA 35 0.0009
722 ALTERED STATE OF CONSCIOUSNESS 20 0.0009
723 MYOCARDIAL INFARCTION 161 0.0009
724 SKIN REACTION 13 0.0009
725 PLATELET COUNT INCREASED 12 0.0009
726 SKIN LACERATION 10 0.0009
727 RENAL FAILURE ACUTE 39 0.0009
728 DEAFNESS 24 0.0009
729 SINUS TACHYCARDIA 13 0.0009
730 RHINORRHOEA 59 0.0009
731 BACTERIAL INFECTION 17 0.0009
732 TOOTH INFECTION 12 0.0009
733 MEMORY IMPAIRMENT 125 0.0009
734 SWELLING 85 0.0009
735 ANGINA PECTORIS 26 0.0009
736 RESPIRATORY DISTRESS 25 0.0009
737 BLOOD POTASSIUM DECREASED 27 0.0009
738 URINARY TRACT INFECTION 153 0.0009
739 THERAPY INTERRUPTED 64 0.0009
740 GASTROINTESTINAL INFECTION 8 0.0009
741 TOXICITY TO VARIOUS AGENTS 150 0.0009
742 FACE OEDEMA 15 0.0009
743 CHEST DISCOMFORT 91 0.0009
744 ARRHYTHMIA 42 0.0009
745 CARDIAC FAILURE CONGESTIVE 71 0.0009
746 MOTOR DYSFUNCTION 9 0.0009
747 TREATMENT FAILURE 73 0.0009
748 PELVIC PAIN 16 0.0009
749 LEUKOPENIA 44 0.0009
750 ERUCTATION 17 0.0009
751 PRODUCT USE ISSUE 165 0.0009
752 INITIAL INSOMNIA 9 0.0009
753 CHOLECYSTECTOMY 10 0.0009
754 TEMPERATURE INTOLERANCE 9 0.0009
755 URINARY RETENTION 29 0.0009
756 VENTRICULAR EXTRASYSTOLES 9 0.0009
757 CARDIOVASCULAR DISORDER 22 0.0009
758 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
759 COMA 41 0.0009
760 EYE DISORDER 28 0.0009
761 HEAD DISCOMFORT 15 0.0008
762 DEVICE RELATED INFECTION 13 0.0008
763 NECK PAIN 47 0.0008
764 DIZZINESS 417 0.0008
765 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
766 LOCALISED INFECTION 20 0.0008
767 DIZZINESS POSTURAL 8 0.0008
768 CLOSTRIDIUM DIFFICILE INFECTION 18 0.0008
769 VISUAL IMPAIRMENT 102 0.0008
770 HAIR TEXTURE ABNORMAL 11 0.0008
771 CHOKING 16 0.0008
772 GASTROINTESTINAL PAIN 9 0.0008
773 VISION BLURRED 112 0.0008
774 CELLULITIS 41 0.0008
775 BLOOD GLUCOSE DECREASED 39 0.0008
776 PAIN IN JAW 23 0.0008
777 FEELING ABNORMAL 194 0.0008
778 NEUROPATHY PERIPHERAL 77 0.0008
779 DEPRESSED LEVEL OF CONSCIOUSNESS 32 0.0008
780 HYPOAESTHESIA 121 0.0008
781 FEMUR FRACTURE 25 0.0008
782 TREATMENT NONCOMPLIANCE 44 0.0008
783 SYNCOPE 80 0.0008
784 BALANCE DISORDER 69 0.0008
785 STATUS EPILEPTICUS 9 0.0008
786 PNEUMOCYSTIS JIROVECII PNEUMONIA 8 0.0008
787 CHOLELITHIASIS 26 0.0008
788 ARTHRALGIA 329 0.0008
789 HYPOMAGNESAEMIA 11 0.0008
790 DEMENTIA 22 0.0008
791 ERYTHEMA 160 0.0008
792 RIB FRACTURE 16 0.0008
793 NIGHT SWEATS 25 0.0008
794 GASTROENTERITIS VIRAL 14 0.0008
795 MADAROSIS 9 0.0008
796 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
797 DISCOMFORT 47 0.0008
798 CONVULSION 44 0.0008
799 CHILLS 90 0.0008
800 LOSS OF CONSCIOUSNESS 98 0.0008
801 RASH MACULO-PAPULAR 17 0.0008
802 LACRIMATION INCREASED 23 0.0008
803 BLINDNESS 31 0.0008
804 ANOSMIA 11 0.0008
805 BLOOD GLUCOSE ABNORMAL 14 0.0008
806 THERAPEUTIC RESPONSE UNEXPECTED 34 0.0008
807 HYPOKINESIA 11 0.0008
808 FLUID OVERLOAD 11 0.0008
809 GASTROENTERITIS 11 0.0008
810 EPILEPSY 23 0.0008
811 ABSCESS 12 0.0008
812 ACUTE MYOCARDIAL INFARCTION 22 0.0007
813 FULL BLOOD COUNT DECREASED 15 0.0007
814 PAIN OF SKIN 20 0.0007
815 LACTIC ACIDOSIS 24 0.0007
816 DEPRESSED MOOD 39 0.0007
817 ASPIRATION 8 0.0007
818 LOWER RESPIRATORY TRACT INFECTION 33 0.0007
819 RASH PRURITIC 39 0.0007
820 TOOTH DISORDER 16 0.0007
821 ORAL HERPES 14 0.0007
822 DEEP VEIN THROMBOSIS 46 0.0007
823 ACTIVITIES OF DAILY LIVING IMPAIRED 14 0.0007
824 RESPIRATORY DISORDER 21 0.0007
825 SUBDURAL HAEMATOMA 10 0.0007
826 TACHYCARDIA 62 0.0007
827 VISUAL ACUITY REDUCED 23 0.0007
828 SEPTIC SHOCK 30 0.0007
829 ILLNESS 71 0.0007
830 FRACTURE 13 0.0007
831 INTERVERTEBRAL DISC PROTRUSION 15 0.0007
832 ADVERSE REACTION 9 0.0007
833 HYPOTENSION 136 0.0007
834 ACUTE RESPIRATORY FAILURE 13 0.0007
835 RASH ERYTHEMATOUS 32 0.0007
836 VENTRICULAR TACHYCARDIA 11 0.0007
837 LEUKOCYTOSIS 12 0.0007
838 KIDNEY INFECTION 13 0.0007
839 NASOPHARYNGITIS 122 0.0007
840 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 47 0.0007
841 VERTIGO 40 0.0007
842 HYPOXIA 23 0.0007
843 SPINAL FRACTURE 13 0.0006
844 LYMPHOMA 10 0.0006
845 HUNGER 9 0.0006
846 HERPES ZOSTER 37 0.0006
847 SCAR 11 0.0006
848 RENAL INJURY 19 0.0006
849 NEPHROLITHIASIS 29 0.0006
850 MUSCLE ATROPHY 8 0.0006
851 TINNITUS 29 0.0006
852 SOMNOLENCE 127 0.0006
853 PULMONARY FIBROSIS 12 0.0006
854 PARAESTHESIA ORAL 9 0.0006
855 MENTAL IMPAIRMENT 15 0.0006
856 BLOOD PRESSURE DECREASED 41 0.0006
857 INFLUENZA 68 0.0006
858 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 109 0.0006
859 UPPER LIMB FRACTURE 12 0.0006
860 INSOMNIA 160 0.0006
861 COAGULOPATHY 10 0.0006
862 CHRONIC KIDNEY DISEASE 45 0.0006
863 FALL 197 0.0006
864 BLOOD CREATINE PHOSPHOKINASE INCREASED 17 0.0006
865 TACHYPNOEA 8 0.0006
866 SLEEP DISORDER 41 0.0006
867 MUSCULOSKELETAL DISORDER 11 0.0006
868 DIABETES MELLITUS 44 0.0006
869 DELIRIUM 20 0.0006
870 STAPHYLOCOCCAL INFECTION 19 0.0006
871 HYPERHIDROSIS 74 0.0006
872 EOSINOPHILIA 10 0.0006
873 PARAESTHESIA 89 0.0006
874 METABOLIC ACIDOSIS 18 0.0006
875 SINUS DISORDER 11 0.0006
876 CATARACT 33 0.0006
877 GASTRIC CANCER 14 0.0006
878 POLLAKIURIA 23 0.0006
879 OFF LABEL USE 479 0.0005
880 DISEASE RECURRENCE 26 0.0005
881 GENERALISED TONIC-CLONIC SEIZURE 9 0.0005
882 MOBILITY DECREASED 39 0.0005
883 HEPATIC CANCER 13 0.0005
884 JOINT SWELLING 65 0.0005
885 PALPITATIONS 63 0.0005
886 SWELLING FACE 35 0.0005
887 HEAD INJURY 17 0.0005
888 COGNITIVE DISORDER 25 0.0005
889 CORONARY ARTERY DISEASE 16 0.0005
890 PRURITUS 202 0.0005
891 FEELING HOT 32 0.0005
892 POST PROCEDURAL COMPLICATION 10 0.0005
893 ACUTE MYELOID LEUKAEMIA 8 0.0005
894 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 28 0.0005
895 VAGINAL HAEMORRHAGE 22 0.0005
896 HEART RATE INCREASED 50 0.0005
897 PROCEDURAL PAIN 14 0.0005
898 THIRST 9 0.0005
899 SCIATICA 8 0.0005
900 PRESCRIBED UNDERDOSE 10 0.0005
901 CYTOKINE RELEASE SYNDROME 10 0.0005
902 OSTEOMYELITIS 9 0.0005
903 STEVENS-JOHNSON SYNDROME 11 0.0005
904 BLOOD CHOLESTEROL INCREASED 23 0.0005
905 ACCIDENTAL OVERDOSE 18 0.0005
906 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 35 0.0005
907 RASH PAPULAR 11 0.0005
908 THROAT IRRITATION 22 0.0005
909 EMOTIONAL DISORDER 15 0.0005
910 DEPRESSION 110 0.0005
911 VIRAL INFECTION 16 0.0005
912 SWOLLEN TONGUE 15 0.0005
913 LIMB INJURY 13 0.0005
914 PHOTOPHOBIA 9 0.0005
915 PERICARDITIS 8 0.0005
916 UPPER RESPIRATORY TRACT INFECTION 22 0.0005
917 WHITE BLOOD CELL COUNT INCREASED 18 0.0005
918 DRUG EFFECT INCOMPLETE 17 0.0005
919 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0005
920 POOR QUALITY SLEEP 10 0.0005
921 AGITATION 34 0.0005
922 PRURITUS GENERALISED 10 0.0005
923 DIPLOPIA 12 0.0005
924 SKIN IRRITATION 21 0.0005
925 OSTEONECROSIS 15 0.0005
926 DISTURBANCE IN ATTENTION 24 0.0004
927 HYPERSENSITIVITY 82 0.0004
928 PNEUMONIA ASPIRATION 11 0.0004
929 PRODUCT AVAILABILITY ISSUE 10 0.0004
930 BRONCHITIS 32 0.0004
931 ARTHRITIS 34 0.0004
932 THINKING ABNORMAL 8 0.0004
933 ANXIETY 122 0.0004
934 EYE PAIN 24 0.0004
935 HOT FLUSH 32 0.0004
936 RESPIRATORY TRACT INFECTION 11 0.0004
937 JOINT INJURY 9 0.0004
938 MIGRAINE 40 0.0004
939 TREMOR 69 0.0004
940 EAR PAIN 8 0.0004
941 NERVOUSNESS 21 0.0004
942 FUNGAL INFECTION 13 0.0004
943 UNRESPONSIVE TO STIMULI 10 0.0004
944 PULMONARY HYPERTENSION 8 0.0004
945 WEIGHT INCREASED 86 0.0004
946 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
947 PRODUCT DOSE OMISSION 25 0.0004
948 CARDIO-RESPIRATORY ARREST 16 0.0004
949 OSTEOARTHRITIS 16 0.0004
950 OXYGEN SATURATION DECREASED 21 0.0004
951 SINUSITIS 38 0.0004
952 CONDITION AGGRAVATED 109 0.0004
953 ANGER 12 0.0004
954 EYE SWELLING 13 0.0003
955 COVID-19 61 0.0003
956 PANCREATIC CARCINOMA 10 0.0003
957 NASAL CONGESTION 20 0.0003
958 EAR INFECTION 9 0.0003
959 ROAD TRAFFIC ACCIDENT 14 0.0003
960 BLOOD GLUCOSE INCREASED 63 0.0003
961 HALLUCINATION 25 0.0003
962 PRESYNCOPE 8 0.0003
963 NO ADVERSE EVENT 59 0.0003
964 INTENTIONAL PRODUCT USE ISSUE 28 0.0003
965 INFLUENZA LIKE ILLNESS 26 0.0003
966 MUSCULOSKELETAL STIFFNESS 27 0.0003
967 URTICARIA 51 0.0003
968 RESTLESSNESS 11 0.0003
969 MENTAL DISORDER 12 0.0003
970 MEDICATION ERROR 15 0.0003
971 ACNE 20 0.0003
972 WHEEZING 15 0.0003
973 UNEVALUABLE EVENT 19 0.0003
974 ECZEMA 13 0.0002
975 DYSKINESIA 10 0.0002
976 DRY EYE 11 0.0002
977 UNDERDOSE 16 0.0002
978 FLUSHING 22 0.0002
979 ARTHROPATHY 12 0.0002
980 INCORRECT DOSE ADMINISTERED 48 0.0002
981 DRUG EFFECT DECREASED 11 0.0002
982 OCULAR HYPERAEMIA 9 0.0002
983 ANGIOEDEMA 8 0.0002
984 PRODUCT DOSE OMISSION ISSUE 53 0.0002
985 ASTHMA 20 0.0002
986 PROSTATE CANCER 14 0.0002
987 SKIN BURNING SENSATION 10 0.0001
988 IRRITABILITY 8 0.0001
989 OVERDOSE 26 0.0001
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 24 0.0001
991 INTENTIONAL PRODUCT MISUSE 10 0.0001
992 BREAST CANCER 9 0.0001
993 PRODUCT QUALITY ISSUE 11 0.0001